ECHOES-CHD

ECHOES-CHD - Early Cardiac Health Observation and Echocardiography Study in Congenital Heart Defect

Table of Content

Lay Summary

At the Montreal Children’s Hospital, we are embarking on an important study to better understand how newborns with congenital heart defects (CHD - abnormal heart anatomy at birth) adjust to life outside the womb. This transition is crucial as it involves important changes in how blood flows occur through the heart and lungs once the baby is disconnected from the mother and the placenta. For infants with heart defects, these changes can complicate their already vulnerable condition, potentially leading to brain injuries and developmental issues. 

Our recent investigations have shown that specific patterns in blood flow can severely affect how blood reaches the brain. To delve deeper, we have gathered a group of newborns with heart defect immediately after birth and followed them for their first week after birth using daily imaging of their heart with ultrasound ("echocardiogram"). We will be analyzing these echocardiograms with advanced imaging techniques such as 3D echocardiography reconstruction and speckle tracking (a method to track the motion of the heart during its contraction and relaxation). These technologies allow us to visualize and quantify the heart's  function with unprecedented detail, enabling a precise assessment of how the heart muscle moves and pumps blood. This might reveal subtle and important abnormalities that conventional scans cannot detect, and how this occurs during the first week after birth, while these infants are experiencing an important transition. 

We have collected comprehensive data on 62 newborns with heart defect, including both 2D and 3D echocardiography-derived images/clips ("videos"). This dataset now must be analyzed using these advanced techniques, which requires resources, expertise and time. This will help us understand the trajectory of the underlying heart function in these newborns and to assess the impact of this critical transition after birth during which disturbances (previously not studies) may affect how important organs are getting nourished in blood and oxygen. 

By analyzing this detailed data, our goal is to pinpoint how these heart defects affect newborns in their first week of life, aiming to improve how we manage and treat these vulnerable patients. Our findings could lead to interventions that are tailored specifically to their needs right after birth, potentially improving their chances of a healthier life. Insights from this study will also guide future research and interventions aimed at preventing complications in newborns with CHD, supported by partnerships with major health foundations.

Rationale

Rationale: Newborns with a congenital heart defect (CHD) undergo the usual post-natal adaptation with a drop in pulmonary vascular resistance (PVR) and an abrupt increase in systemic vascular resistance (SVR) upon placental disconnection. This transition may be accompanied by altered systemic/pulmonary blood flow due to the presence of shunts and adverse underlying cardiac performance, which may lead to compromised cerebral blood flow (CBF). Vulnerabilities during the early cardiovascular transition elevate the risk of brain injuries, potentially contributing to long-term neurodevelopmental challenges1, 2. Newborns with CHD have signs of brain injury prior to surgical correction or palliation 3-6. Decreased preoperative CBF has been described in the CHD population and has been associated with increased incidence of acquired brain injuries and cerebral dysmaturation7, 8. It remains unclear how the underlying cardiac performance differs based on the type of cardiac lesion during this postnatal transitional period 9-11. 


We recently analyzed a cohort of neonates with CHD in a study that assessed Doppler ultrasound profiles of CBF relative to their underlying cardiac physiology in the first week of life 12. We observed that infants exhibiting retrograde flow in the post-ductal arch on the final day of monitoring—a sign of systemic steal into the pulmonary circulation—also demonstrated a marked increase in resistive index of the anterior cerebral artery (ACA), indicating heightened resistance to CBF. Preliminary findings (unpublished, poster 1675766 at PAS 2024) from 34 infants in this cohort who underwent both ACA Doppler and near infrared spectroscopy (NIRS) monitoring, revealed a correlation between cerebral saturation (Csat), an indirect measure of cerebral perfusion, and simultaneous Doppler measurements. Additionally, preliminary data on 49 newborns with CHD and NIRS monitoring showed that retrograde post-ductal aortic flow was linked to reduced CSat, increased cerebral oxygen extraction compared to pre-ductal systemic saturation, and lowered renal saturation in the first week of life (unpublished, poster 1678552 at PAS 2024). These observations suggest that in the pre-interventional and immediate postnatal period, infants with CHD experience flow disturbances detectable by ultrasound and NIRS, influenced by persistent shunts facilitating a steal effect from the systemic to the pulmonary circulation. However, it remains unclear whether changes in underlying cardiac performance contribute to these phenomena, or if specific cardiac performance profiles could potentially modulate these flow parameters as effect modifiers to prevent organ hypoperfusion in the future. 


New echocardiography techniques, such as speckle tracking (STE) and 3D-echocardiography allow the assessment of deformation of the global heart and its circumscribed segments, as well as, cardiac volumes, possibly uncovering subtle performance abnormalities previously undetectable by conventional imaging (Figure). Strain rate by STE correlates with LV peak elastance, a load-independent parameter of systolic function, derived from cardiac catheterization on an animal model 13. This was validated in a CHD pediatric population by catheterization13. Circumferential strain by echocardiography in the adolescent single ventricle population was found to be associated with transplant-free survival and to be more discriminative than clinical assessment 14. Another value of STE is the correlation between 2D-echocardiography longitudinal strain and ejection fraction by magnetic resonance imaging in the single ventricle population15. Hence, there is growing evidence outlining the usefulness of STE analysis of cardiac function in the CHD population 16. However, there is a need for high quality data on the evolution of cardiac performance once PVR drops in the neonatal CHD population. The use of STE and 3D echocardiography will allow refinement of our understanding of the impact of CHD physiologies on cardiac performance. This approach will uncover performance anomalies previously undetected by conventional echocardiographic tools.

Study Design

Aim: Evaluate the impact of transitional physiology on cardiac performance in the newborns with CHD in the first week of life. We hypothesize that: In patients with CHD, cardiac performance is affected differently by underlying ductal physiology upon the drop of PVR in the first week of life. To achieve our aim: We will describe the longitudinal trajectory of cardiac performance by deformation analysis based on the underlying physiology: a) presence or absence of retrograde flow in the post-ductal aorta; b) systemic-dependent ductal circulation, pulmonary-dependent ductal circulation or others. Our primary outcome for statistical analysis will be cardiac function by peak global longitudinal strain (pGLS) using 2D-STE of the systemic ventricle. Our secondary outcomes will be to describe the trends in 3D systemic ventricular deformation analysis (volumes and strain).

 

Methods: A prospective study already recruited newborns with complex CHD admitted at our institution (Montreal Children’s Hospital) and requiring a neonatal intensive care unit (NICU) admission from November 2019 to January 2023. We included infants born at >34 weeks and ≤7 days of life. Exclusion criteria included: diagnosis of a significant genetic or syndromic anomaly, other significant malformation and presence of asphyxia. Echocardiograms were collected daily as part of this multimodal monitoring observational study and represent a rich source of cardiovascular phenotyping that requires post-processing data extraction.

 

Data sources: We enrolled 62 newborns with CHD. Daily echocardiograms were performed until day 7 of life, intervention or discharge (whichever occurred first). These have 2D and 3D clip acquisitions downloaded in raw DICOM format, as well as Doppler assessments (blood and tissue). Patient demographic and clinical information were extracted from the medical chart. Near infrared spectroscopy signals at the cerebral and renal level were collected (every 15 seconds) during the same monitoring period. Routine laboratory values were extracted (gaz, lactate, creatinine, hemoglobin). Echocardiography images were anonymized at acquisition and will be analyzed using TomTEC for 2D and 3D-STE. We are at the step of data extraction of this data, which requires the necessary support for post-processing of these complex imaging signals.

 

Anticipated impact and prospects for future funding sources: We have constructed a rich cohort of 62 newborns with prospective 228 echocardiograms in the first week of life to better phenotype their underlying cardiac profile during the transitional period. This data will be instrumental in designing future studies modulating cardiac performance in the immediate postnatal life with the aim of reduce end-organ or brain injury in an already at-risk population. Future studies will use these thresholds for intervention using targeted management (e.g.: milrinone to improve cardiac performance, inotropic support according to performance, and/or respiratory or volume repletion, etc.). We will describe the cardiac adaptation of these newborns using advanced technologies (3D echocardiography, STE) and based on physiological cardiac categories. This information will eventually tie into daily practice in order to better understand the impact of post-natal transition on cardiac function, blood flow distribution and end-organ perfusion. Future funding will be sought through the Heart and Stroke Foundation, the Canadian Institute of Health Research and the Thrasher Foundation.

2D Speckle-Tracking Echocardiography in CHD

3D Speckle-Tracking Echocardiography in CHD

Team

Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center; Department of Pediatrics. silvia.nogara@ri-muhc.ca


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center; Department of Pediatrics. pasinee.kanaprach@mail.mcgill.ca


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. dra.carolinamichel@gmail.com


Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. emmanouil.rampakakis@mcgill.ca

 

Division of Neonatology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. punnanee.wut@mahidol.edu


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Centre, Department of Pediatrics, McGill University. jessica.simoneau@muhc.mcgill.ca


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. daniela.villegas.martinez@muhc.mcgill.ca   

 

Division of Neonatology, Dana Dwek Children’s Hospital, Tel Aviv Medical Center, Tel-Aviv, Israel. p.shiran@gmail.com


School of Physical and Occupational Therapy, Faculty of Medicine and Health Sciences, McGill University. marie.brossardracine@mcgill.ca


Division of Pediatric Cardiology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. adrian.dancea@mcgill.ca


Division of Pediatric Cardiology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. adrian.dancea@mcgill.ca


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. Pia.wintermark@mcgill.ca


Division of Neonatology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Center. gabriel.altit@mcgill.ca

References

[1] Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126:1143-72.

[2] Peyvandi S, Donofrio MT. Circulatory Changes and Cerebral Blood Flow and Oxygenation During Transition in Newborns With Congenital Heart Disease. Semin Pediatr Neurol. 2018;28:38-47.

[3] Block A, McQuillen P, Chau V, Glass H, Poskitt K, Barkovich A, et al. Clinically silent preoperative brain injuries do not worsen with surgery in neonates with congenital heart disease. The Journal of thoracic and cardiovascular surgery. 2010;140:550-7.

[4] Sun L, Macgowan CK, Sled JG, Yoo S-J, Manlhiot C, Porayette P, et al. Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation. 2015:CIRCULATIONAHA. 114.013051.

[5] Dimitropoulos A, McQuillen PS, Sethi V, Moosa A, Chau V, Xu D, et al. Brain injury and development in newborns with critical congenital heart disease. Neurology. 2013;81:241-8.

[6] Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, et al. Brain maturation is delayed in infants with complex congenital heart defects. The Journal of thoracic and cardiovascular surgery. 2009;137:529-37.

[7] Licht DJ, Wang J, Silvestre DW, Nicolson SC, Montenegro LM, Wernovsky G, et al. Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. The Journal of Thoracic and Cardiovascular Surgery. 2004;128:841-9.

[8] Brossard-Racine M, du Plessis A, Vezina G, Robertson R, Donofrio M, Tworetzky W, et al. Brain injury in neonates with complex congenital heart disease: what is the predictive value of MRI in the fetal period? American Journal of Neuroradiology. 2016;37:1338-46.

[9] Mebius MJ, van der Laan ME, Verhagen EA, Roofthooft MT, Bos AF, Kooi EM. Cerebral oxygen saturation during the first 72h after birth in infants diagnosed prenatally with congenital heart disease. Early Human Development. 2016;103:199-203.

[10] Uebing A, Furck AK, Hansen JH, Nufer E, Scheewe J, Dütschke P, et al. Perioperative cerebral and somatic oxygenation in neonates with hypoplastic left heart syndrome or transposition of the great arteries. The Journal of thoracic and cardiovascular surgery. 2011;142:523-30.

[11] Altit G, Bhombal S, Tacy TA, Chock VY. End-Organ Saturation Differences in Early Neonatal Transition for Left- versus Right-Sided Congenital Heart Disease. Neonatology. 2018;114:53-61.

[12] Mir M, Moore SS, Wutthigate P, Simoneau J, Villegas Martinez D, Shemie SD, et al. Newborns with a Congenital Heart Defect and Diastolic Steal Have an Altered Cerebral Arterial Doppler Profile. J Pediatr. 2023;257:113369.

[13] Schlangen J, Petko C, Hansen JH, Michel M, Hart C, Uebing A, et al. Two dimensional global longitudinal strain rate is a preload independent index of systemic right ventricular contractility in hypoplastic left heart syndrome patients after Fontan operation. Circulation: Cardiovascular Imaging. 2014:CIRCIMAGING. 114.002110.

[14] Ghelani SJ, Harrild DM, Gauvreau K, Geva T, Rathod RH. Comparison between echocardiography and cardiac magnetic resonance imaging in predicting transplant-free survival after the Fontan operation. The American journal of cardiology. 2015;116:1132-8.

[15] Ruotsalainen H, Bellsham-Revell H, Bell A, Pihkala J, Ojala T, Simpson J. Right ventricular systolic function in hypoplastic left heart syndrome: a comparison of velocity vector imaging and magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2015:jev196.

[16] Ghelani SJ, Harrild DM, Gauvreau K, Geva T, Rathod RH. Echocardiography and magnetic resonance imaging based strain analysis of functional single ventricles: a study of intra-and inter-modality reproducibility. The international journal of cardiovascular imaging. 2016;32:1113-20.

Created by Gabriel Altit - Neonatologist / Créé par Gabriel Altit (néonatalogiste) - © NeoCardioLab - 2020-2024 - Contact us / Contactez-nous